Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $140.3900 (0.12%) ($140.1000 - $142.8400) on Tue. Aug. 2, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.37% (three month average) | RSI | 29 | Latest Price | $140.3900(0.12%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -1.4% a day on average for past five trading days. | Weekly Trend | ABBV declines -2.1% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(34%) DIA(25%) SPLV(24%) XLP(24%) VYM(23%) | Factors Impacting ABBV price | ABBV will decline at least -0.685% in a week (0% probabilities). VIXM(-15%) UUP(-13%) TBT(-3%) UNG(-1%) VXX(2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.685% (StdDev 1.37%) | Hourly BBV | -1.1 () | Intraday Trend | -0.7% | | | |
|
Resistance Level | $149.24 | 5 Day Moving Average | $145(-3.18%) | 10 Day Moving Average | $146.84(-4.39%) | 20 Day Moving Average | $149.24(-5.93%) | To recent high | -9.7% | To recent low | 2% | Market Cap | $247.688b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |